486 related articles for article (PubMed ID: 30006164)
1. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
Zhao M; Zheng YH; Zhao QY; Zheng W; Yang JH; Pei HY; Liu L; Liu KJ; Xue LL; Deng DX; Wang L; Ma X; Fu SH; Peng AH; Tang MH; Luo YZ; Ye HY; Chen LJ
Eur J Med Chem; 2021 Jan; 209():112922. PubMed ID: 33069436
[TBL] [Abstract][Full Text] [Related]
3. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
[TBL] [Abstract][Full Text] [Related]
4. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
[TBL] [Abstract][Full Text] [Related]
5. Advances on Semisynthesis, Total Synthesis, and Structure-Activity Relationships of Honokiol and Magnolol Derivatives.
Yang C; Zhi X; Xu H
Mini Rev Med Chem; 2016; 16(5):404-26. PubMed ID: 26586125
[TBL] [Abstract][Full Text] [Related]
6. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
7. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
Deng S; Zhang C; Yang L; Ma L
Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
[TBL] [Abstract][Full Text] [Related]
8. Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway.
Li M; Zhang F; Wang X; Wu X; Zhang B; Zhang N; Wu W; Wang Z; Weng H; Liu S; Gao G; Mu J; Shu Y; Bao R; Cao Y; Lu J; Gu J; Zhu J; Liu Y
Cancer Sci; 2015 Oct; 106(10):1341-50. PubMed ID: 26250568
[TBL] [Abstract][Full Text] [Related]
9. Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells.
Yang J; Wu W; Wen J; Ye H; Luo H; Bai P; Tang M; Wang F; Zheng L; Yang S; Li W; Peng A; Yang L; Wan L; Chen L
Biomaterials; 2017 Oct; 141():188-198. PubMed ID: 28689115
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
Singh T; Prasad R; Katiyar SK
Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
[TBL] [Abstract][Full Text] [Related]
11. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
[TBL] [Abstract][Full Text] [Related]
12. Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway.
Park JB; Lee MS; Cha EY; Lee JS; Sul JY; Song IS; Kim JY
Biol Pharm Bull; 2012; 35(9):1614-20. PubMed ID: 22975518
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Characterization and Biological Evaluation of Magnolol and Honokiol Derivatives with 1,3,5-Triazine of Metformin Cyclization.
Ren C; Wang J; Tan Y; Guo M; Guo J; Liu Y; Wu X; Feng Y
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302335
[TBL] [Abstract][Full Text] [Related]
14. Anticancer potential of magnolol for lung cancer treatment.
Seo JU; Kim MH; Kim HM; Jeong HJ
Arch Pharm Res; 2011 Apr; 34(4):625-33. PubMed ID: 21544728
[TBL] [Abstract][Full Text] [Related]
15. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
[TBL] [Abstract][Full Text] [Related]
16. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
17. Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells.
Tsai JR; Chong IW; Chen YH; Hwang JJ; Yin WH; Chen HL; Chou SH; Chiu CC; Liu PL
Arch Pharm Res; 2014 Apr; 37(4):548-57. PubMed ID: 23943503
[TBL] [Abstract][Full Text] [Related]
18. CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis.
Chen J; Tao C; Huang X; Chen Z; Wang L; Li X; Ma M; Wu Z
Bioorg Med Chem; 2020 Mar; 28(6):115352. PubMed ID: 32044229
[TBL] [Abstract][Full Text] [Related]
19. Overcoming acquired resistance of EGFR-mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol.
Zang H; Qian G; Arbiser J; Owonikoko TK; Ramalingam SS; Fan S; Sun SY
Mol Oncol; 2020 Apr; 14(4):882-895. PubMed ID: 32003107
[TBL] [Abstract][Full Text] [Related]
20. Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer.
Ranaware AM; Banik K; Deshpande V; Padmavathi G; Roy NK; Sethi G; Fan L; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]